Skip to main content
. 2020 Jul 2;10:10853. doi: 10.1038/s41598-020-66579-5

Table 3.

Best response in 18 patients with metastatic disease receiving chemotherapy (RECIST 1.1).

Regimen n° (%) of pts Best Result (RECIST 1.1)
PR SD PD
Doxorubicin- Ifosfamide 8 (44) 2 6
Osteosarcoma-like 4 (22) 1 3
Paclitaxel 3 (17) 1 2
Gemcitabine 2 (11) 2
Caelix 1 (6) 1

*Standard doxorubicin or pegylated liposomal doxorubicin.